Literature DB >> 23520135

Fat overload syndrome after the rapid infusion of SMOFlipid emulsion.

Iva Hojsak1, Sanja Kolaček.   

Abstract

Fat overload syndrome is a well-known complication of intravenous lipid emulsion therapy. It is characterized by headaches, fever, jaundice, hepatosplenomegaly, respiratory distress, and spontaneous hemorrhage. Other symptoms include anemia, leukopenia, thrombocytopenia, low fibrinogen levels, and coagulopathy. Several reports in the literature describe fat overload syndrome caused by rapid infusion of lipid emulsions, all with soybean-based lipid emulsions. We report fat overload syndrome in a 2-year-old girl with short bowel syndrome on home parenteral nutrition. Fat overload syndrome occurred as a result of accidental, very rapid infusion of a 20% soy oil, medium-chain triglyceride, olive and fish oil-based lipid emulsion (SMOFlipid) that showed the same complications seen with an earlier lipid emulsion (Intralipid). The patient was successfully treated with supportive care combining fluid infusion, transfusion of platelets, and substitution of serum albumin (0.5 g/kg/d) and fresh-frozen plasma (10 mL/kg). In the next couple of days, she received extra platelets, erythrocyte transfusion, and filgrastim (Neupogen; 5 µg/kg/d) due to a very low leukocyte count. To the best of our knowledge, this is the first case of fat overload syndrome caused by SMOFlipid emulsion described in the literature.

Entities:  

Keywords:  SMOFlipids; children; lipid emulsion; lipid overload syndrome; parenteral nutrition

Mesh:

Substances:

Year:  2013        PMID: 23520135     DOI: 10.1177/0148607113482001

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  6 in total

Review 1.  Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Meredith A Baker; Gillian L Fell; Mark Puder; Kathleen M Gura
Journal:  Nutr Clin Pract       Date:  2016-08-16       Impact factor: 3.080

2.  Individualization of the infusion rate of a soybean oil-based intravenous lipid emulsion for inpatients, based on baseline triglyceride concentrations: A population pharmacokinetic approach.

Authors:  Keizo Fukushima; Kenji Omura; Satoshi Goshi; Akira Okada; Motomu Tanaka; Takae Tsujimoto; Keiji Iriyama; Nobuyuki Sugioka
Journal:  JPEN J Parenter Enteral Nutr       Date:  2021-05-12       Impact factor: 3.896

3.  Risk of Liver Injury Associated with Intravenous Lipid Emulsions: A Prescription Sequence Symmetry Analysis.

Authors:  Xiao-Xiao Li; Yin-Chu Cheng; Suo-di Zhai; Peng Yao; Si-Yan Zhan; Lu-Wen Shi
Journal:  Front Pharmacol       Date:  2021-03-01       Impact factor: 5.810

Review 4.  Intravenous Lipid Emulsion Overdose in Infancy: A Case Report and Overview of Opportunities, Challenges and Prevention.

Authors:  Wasim Khasawneh; Salar Bani Hani
Journal:  Drug Saf Case Rep       Date:  2018-03-19

5.  Which is the best in carbamazepine overdose?

Authors:  Kıvanç Karaman; Kenan Ahmet Türkdoğan; Ahmet Tunç Deniz; Selçuk Eren Çanakçı
Journal:  Clin Case Rep       Date:  2017-08-22

6.  Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial.

Authors:  Faheem W Guirgis; Lauren Page Black; Elizabeth DeVos; Morgan Henson; Jason Ferreira; Taylor Miller; Martin Rosenthal; Christiaan Leeuwenburgh; Colleen Kalynych; Lyle Moldawer; Lisa Jones; Marie Crandall; Srinivasa T Reddy; Hanzhi Gao; Sam Wu; Frederick Moore
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.